Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.825
+0.160 (3.43%)
Apr 8, 2026, 9:22 AM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.45 billion as of April 7, 2026. Its market cap has increased by 31.78% in one year.
Market Cap
1.45B
Enterprise Value
1.76B
Revenue
626.99M
Ranking
n/a
PE Ratio
18.37
Stock Price
€4.83
Market Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.45B, an increase of 787.59%. That is a compound annual growth rate of 7.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.46B | -9.01% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 4.23B |
| Almirall | 2.65B |
| Pharma Mar | 1.58B |
| Clínica Baviera | 767.29M |
| Atrys Health | 217.76M |
| Prim, S.A. | 216.95M |
| Oryzon Genomics | 216.26M |